The pathophysiology of elevated vitamin B12 in clinical practice

被引:145
作者
Andres, E. [1 ]
Serraj, K. [1 ]
Zhu, J. [2 ]
Vermorken, A. J. M. [2 ]
机构
[1] Univ Hosp Strasbourg, Dept Internal Med Diabet & Metab Disorders, F-67091 Strasbourg, France
[2] Katholieke Univ Leuven, Lab Mol Oncol, Dept Human Genet, B-3000 Louvain, Belgium
关键词
PERNICIOUS-ANEMIA; COBALAMIN VITAMIN-B12; SERUM VITAMIN-B12; TRANSCOBALAMIN-I; ETIOLOGIC RELATIONSHIP; METHYLMALONIC ACID; ACHYLIA GASTRICA; BINDING-PROTEIN; HOLOTRANSCOBALAMIN-II; HOMOCYSTEINE STATUS;
D O I
10.1093/qjmed/hct051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypercobalaminemia (high serum vitamin B12 levels) is a frequent and underestimated anomaly. Clinically, it can be paradoxically accompanied by signs of deficiency, reflecting a functional deficiency linked to qualitative abnormalities, which are related to defects in tissue uptake and action of vitamin B12. The aetiological profile of high serum cobalamin predominantly encompasses severe disease entities for which early diagnosis is critical for prognosis. These entities are essentially comprised of solid neoplasms, haematological malignancies and liver and kidney diseases. This review reflects the potential importance of the vitamin B12 assay as an early diagnostic marker of these diseases. A codified approach is needed to determine the potential indications of a search for high serum cobalamin and the practical clinical strategy to adopt upon discovery of elevated cobalamin levels. While low serum cobalamin levels do not necessarily imply deficiency, an abnormally high serum cobalamin level forms a warning sign requiring exclusion of a number of serious underlying pathologies. Functional cobalamin deficiency can thus occur at any serum level.
引用
收藏
页码:505 / 515
页数:11
相关论文
共 87 条
  • [1] Cobalamin deficiencies in adults:: update of etiologies, clinical manifestations and treatment
    Andrès, E
    Affenberger, S
    Vinzio, S
    Noel, E
    Kaltenbach, G
    Schlienger, JL
    [J]. REVUE DE MEDECINE INTERNE, 2005, 26 (12): : 938 - 946
  • [2] Effects of oral crystalline cyanocobalamin 1000 μg/d in the treatment of pernicious anemia:: An open-label, prospective study in ten patients
    Andrès, E
    Loukili, NH
    Noel, E
    Maloisel, F
    Vinzio, S
    Kaltenbach, G
    Caro-Sampara, F
    Blicklé, JF
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2005, 66 (01): : 13 - 22
  • [3] Vitamin B12 (cobalamin) deficiency in elderly patients
    Andrès, E
    Loukili, NH
    Noel, E
    Kaltenbach, G
    Ben Abdelgheni, M
    Perrin, AE
    Noblet-Dick, M
    Maloisel, F
    Schlienger, JL
    Blicklé, JF
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (03) : 251 - 259
  • [4] Andres E, 2009, ANN ENDOCRINOL, V70, P453
  • [5] Clinical aspects of cobalamin deficiency in elderly patients.: Epidemiology, causes, clinical manifestations, and treatment with special focus on oral cobalamin therapy
    Andres, Emmanuel
    Vidal-Alaball, Josep
    Federici, Laure
    Loukili, Noureddine Henoun
    Zimmer, Jacques
    Kaltenbach, Georges
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2007, 18 (06) : 456 - 462
  • [6] Efficacy of oral cobalamin (vitamin B12) therapy
    Andres, Emmanuel
    Fothergill, Helen
    Mecili, Mustapha
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (02) : 249 - 256
  • [7] Cobalamin Related Parameters and Disease Patterns in Patients with Increased Serum Cobalamin Levels
    Arendt, Johan F. B.
    Nexo, Ebba
    [J]. PLOS ONE, 2012, 7 (09):
  • [8] ARNALICH F, 1990, J MED, V21, P277
  • [9] Cobalamin (vitamin B12) and holotranscobalamin changes in plasma and liver tissue in alcoholics with liver disease
    Baker, H
    Leevy, CB
    DeAngelis, B
    Frank, O
    Baker, ER
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1998, 17 (03) : 235 - 238
  • [10] Markedly increased vitamin B12 concentrations attributable to IgG-IgM-vitamin B12 immune complexes
    Bowen, Raffick A. R.
    Drake, Steven K.
    Vanjani, Rachna
    Huey, Edward D.
    Grafman, Jordan
    Horne, McDonald K., III
    [J]. CLINICAL CHEMISTRY, 2006, 52 (11) : 2107 - 2114